keyword
https://read.qxmd.com/read/38644767/-bcat1-ikzf1-and-sept9-methylated-dna-biomarkers-for-detection-of-pan-gastrointestinal-adenocarcinomas
#1
JOURNAL ARTICLE
Geraldine Laven-Law, Ganessan Kichenadasse, Graeme P Young, Erin L Symonds, Jean M Winter
INTRODUCTION: Methylated circulating tumour DNA (ctDNA) blood tests for BCAT1/IKZF1 (COLVERA) and SEPT9 (Epi proColon) are used to detect colorectal cancer (CRC). However, there are no ctDNA assays approved for other gastrointestinal adenocarcinomas. We aimed to characterize BCAT1, IKZF1 and SEPT9 methylation in different gastrointestinal adenocarcinoma and non-gastrointestinal tumours to determine if these validated CRC biomarkers might be useful for pan-gastrointestinal adenocarcinoma detection...
April 22, 2024: Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
https://read.qxmd.com/read/38643004/-68-ga-fapi-04-positron-emission-tomography-ct-and-laparoscopy-for-the-diagnosis-of-occult-peritoneal-metastasis-in-newly-diagnosed-locally-advanced-gastric-cancer-study-protocol-of-a-single-centre-prospective-cohort-study
#2
JOURNAL ARTICLE
Shunyu Zhang, Qiancheng Hu, Xinchuan Chen, Nan Zhou, Qiyue Huang, Sirui Tan, Minggang Su, Hongfeng Gou
INTRODUCTION: Accurate baseline clinical staging is critical to inform treatment decision-making for patients with gastric cancers. Peritoneal metastasis (PM) is the most common form of metastasis in gastric cancer and mainly diagnosed by diagnostic laparoscopy and peritoneal lavage evaluation. However, diagnostic laparoscopy is invasive and less cost-effective. It is urgent to develop a safe, fast and non-invasive functional imaging method to verify the peritoneal metastasis of gastric cancer...
April 19, 2024: BMJ Open
https://read.qxmd.com/read/38642419/detrimental-impact-of-late-onset-pneumonia-on-long-term-prognosis-in-oesophageal-cancer-survivors
#3
JOURNAL ARTICLE
Hiroto Takiguchi, Kazuo Koyanagi, Soji Ozawa, Tsuyoshi Oguma, Koichiro Asano
BACKGROUD: Oesophageal cancer patients are prone to early- and late-onset pneumonia after oesophagectomy. We aimed to investigate the incidence rate and impact on the long-term prognosis of late-onset pneumonia in oesophageal cancer survivors who survived for at least one year after oesophagectomy without cancer recurrence. METHODS: We retrospectively reviewed 233 patients with thoracic oesophageal cancer who underwent oesophagectomy with gastric conduit reconstruction between September 2009 and June 2019 at a tertiary referral hospital in Japan...
April 19, 2024: Respiratory Investigation
https://read.qxmd.com/read/38641363/hypoxia-inducible-factor-1%C3%AE-mediates-reflux-induced-epithelial-mesenchymal-plasticity-in-barrett-s-oesophagus-patients
#4
JOURNAL ARTICLE
Qiuyang Zhang, Kerry B Dunbar, Robert D Odze, Agoston T Agoston, Xuan Wang, Tianhong Su, Anh D Nguyen, Xi Zhang, Stuart Jon Spechler, Rhonda F Souza
INTRODUCTION: Epithelial-mesenchymal plasticity (EMP), the process through which epithelial cells acquire mesenchymal features, is needed for wound repair but also might contribute to cancer initiation. Earlier, in vitro studies showed that Barrett's cells exposed to acidic bile salt solutions (ABS) develop EMP. Now, we have (1) induced reflux oesophagitis in Barrett's oesophagus (BO) patients by stopping proton pump inhibitors (PPIs), (2) assessed their biopsies for EMP and (3) explored molecular pathways underlying reflux-induced EMP in BO cells and spheroids...
April 19, 2024: Gut
https://read.qxmd.com/read/38631975/systematic-review-of-hypofractionated-radiation-therapy-for-the-treatment-of-oesophageal-squamous-cell-carcinoma-and-oesophageal-adenocarcinoma
#5
JOURNAL ARTICLE
C Sanghera, D P McClurg, C M Jones
BACKGROUND AND AIM: There has been limited progress made in improving the suboptimal outcomes delivered by conventionally fractionated radiotherapy (RT) for oesophageal adenocarcinoma (OAC) and squamous cell carcinoma (OSCC). A greater biological effect may be achieved using hypofractionated RT (HFRT), though the toxicity, tolerability and efficacy of this approach in OAC and OSCC is uncertain. METHODS: A systematic literature review was carried out in accordance with Preferred Reporting Items for Systematic Reviews guidance...
March 18, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists
https://read.qxmd.com/read/38630793/residual-cancer-cells-after-apparent-complete-pathological-response-to-neoadjuvant-therapy-in-oesophageal-adenocarcinoma
#6
JOURNAL ARTICLE
Robert C Walker, Jack Harrington, Stella P Breininger, Oliver Pickering, Samuel L Hill, Benjamin P Sharpe, Ben Grace, Ian Reddin, Rushda Rajak, Antigoni Manousopoulou, Spiros D Garbis, Zoë S Walters, Matthew J J Rose-Zerilli, Timothy J Underwood
No abstract text is available yet for this article.
April 3, 2024: British Journal of Surgery
https://read.qxmd.com/read/38629277/x-ray-guided-self-expandable-metal-stent-sems-implantation-in-oesophageal-malignancy-as-an-alternative-treatment
#7
JOURNAL ARTICLE
Damian Ziaja, Mariola Sznapka, Bartłomiej Stasiów, Krzysztof Ziaja, Jerzy Chudek
<b><br>Indroduction:</b> Significant dysphagia, aspiration pneumonia, and impossible oral nutrition in patients with unresectable or recurrent gastroesophageal malignancy or bronchial cancer invading the oesophagus with a tracheoesophageal fistula lead to cachexia. Dehiscence of the esophago-jejunal or gastroesophageal anastomosis may cause severe oesophageal haemorrhage. We believe that X-ray-guided oesophageal stent implantation (SEMS) is an alternative palliative method for microjejunostomy or full parenteral nutrition...
April 2, 2024: Polski Przeglad Chirurgiczny
https://read.qxmd.com/read/38622571/effect-of-oesophagectomy-on-lipid-profiles-in-patients-with-oesophageal-cancer-combined-with-hyperlipidaemia-a-retrospective-study
#8
JOURNAL ARTICLE
Jingrong Yang, Yaxin Li, Jialei Huang, Jiabin Lai, Xiangrui Chen, Wenxuan Xia, Yu Wang
BACKGROUND: Surgery is widely regarded as a pivotal therapeutic approach for treating oesophageal cancer, and clinical observations have revealed that many oesophageal cancer patients also present with concomitant hyperlipidaemia. It is surprising that few studies have been performed to determine how blood lipid levels are affected by oesophageal cancer resection. This research was designed to assess the influence of oesophageal cancer resection on lipid profiles among individuals diagnosed with both oesophageal cancer and hyperlipidaemia...
April 15, 2024: Lipids in Health and Disease
https://read.qxmd.com/read/38618203/camrelizumab-chemotherapy-and-apatinib-in-the-neoadjuvant-treatment-of-resectable-oesophageal-squamous-cell-carcinoma-a-single-arm-phase-2-trial
#9
JOURNAL ARTICLE
Zixiang Wu, Chuanqiang Wu, Jing Zhao, Cong Wu, Haixian Peng, Qi Wang, Rui Bai, Xuefeng Fang, Hong He, Hong Shen, Ming Wu
BACKGROUND: In resectable oesophageal squamous cell carcinoma (ESCC), the efficacy of camrelizumab combined with chemotherapy and apatinib followed by minimally invasive oesophagectomy is not clear. We aimed to fill this knowledge gap. METHODS: This investigator-initiated, single-arm, prospective, phase 2 trial was performed at the Second Affiliated Hospital of Zhejiang University, China. Patients (aged 18-75 years) who were histologically or cytologically diagnosed with ESCC were deemed suitable to participate in this trial...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38618181/pyrimethamine-reduced-tumour-growth-in-pre-clinical-cancer-models-a-systematic-review-to-identify-potential-pre-clinical-studies-for-subsequent-human-clinical-trials
#10
REVIEW
Sivananthan Manoharan, Lee Ying Ying
Pyrimethamine (PYR), a STAT3 inhibitor, has been shown to reduce tumour burden in mouse cancer models. It is unclear how much of a reduction occurred or whether the PYR dosages and route of administration used in mice were consistent with the FDA's recommendations for drug repurposing. Search engines such as ScienceDirect, PubMed/MEDLINE, and other databases, including Google Scholar, were thoroughly searched, as was the reference list. The systematic review includes fourteen (14) articles. The risk of bias (RoB) was assessed using SYRCLE's guidelines...
2024: Biology Methods and Protocols
https://read.qxmd.com/read/38613995/predictors-of-anastomotic-leak-and-conduit-necrosis-after-oesophagectomy-results-from-the-oesophago-gastric-anastomosis-audit-ogaa
#11
JOURNAL ARTICLE
Ewen A Griffiths
BACKGROUND: Both anastomotic leak (AL) and conduit necrosis (CN) after oesophagectomy are associated with high morbidity and mortality. Therefore, the identification of preoperative, modifiable risk factors is desirable. The aim of this study was to generate a risk scoring model for AL and CN after oesophagectomy. METHODS: Patients undergoing curative resection for oesophageal cancer were identified from the international Oesophagogastric Anastomosis Audit (OGAA) from April 2018-December 2018...
March 7, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38613258/prognostic-impact-of-muscle-mass-loss-in-elderly-patients-with-oesophageal-cancer-receiving-neoadjuvant-chemoradiation-therapy
#12
JOURNAL ARTICLE
Jeong Yun Jang, Dongryul Oh, Jae Myoung Noh, Jong-Mu Sun, Hong Kwan Kim, Young Mog Shim
BACKGROUND: We aimed to identify the impact of muscle mass on locally advanced oesophageal cancer (LAEC) in elderly patients receiving neoadjuvant chemoradiation therapy (NACRT). METHODS: We reviewed the medical records of 345 patients diagnosed with LAEC who underwent NACRT and surgery. Physical variables, including height, weight, skeletal muscle mass, and laboratory values, were obtained before and after NACRT. Body mass index (BMI, kg/m2 ), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) were calculated as height/(weight)2 , ANC/ALC, platelet count/ALC, and (10 × albumin + 0...
April 13, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38601581/cathepsin-l-promotes-oesophageal-squamous-cell-carcinoma-development-and-may-be-associated-with-tumour-associated-macrophages
#13
JOURNAL ARTICLE
Zhenhu Zhang, Jianyu Wang, Yamin Shi, Ben Wang, Dong Wang
BACKGROUND: Oesophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths worldwide because existing treatments are often insufficient. Therefore, new, reliable biomarkers must be identified. CTSL overexpression is closely associated with tumour progression and poor prognosis. However, the role and mechanism of CTSL as an oncogene in ESCC remain unclear. METHODS: Genome-wide association study (GWAS) data were used for Mendelian randomization analysis to investigate the possible relationships between CTSL and ESCC...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38600327/spp1-represents-a-therapeutic-target-that-promotes-the-progression-of-oesophageal-squamous-cell-carcinoma-by-driving-m2-macrophage-infiltration
#14
JOURNAL ARTICLE
Chen Wang, Yutong Li, Linhong Wang, Yu Han, Xiaohui Gao, Tiandong Li, Man Liu, Liping Dai, Renle Du
BACKGROUND: Tumour-associated macrophages (TAMs) are an important component of the tumour microenvironment (TME). However, the crosstalk between oesophageal squamous cell carcinoma (ESCC) cells and TAMs remains largely unexplored. METHODS: Clinical samples and the TCGA database were used to evaluate the relevance of SPP1 and TAM infiltration in ESCC. Mouse models were constructed to investigate the roles of macrophages educated by SPP1 in ESCC. Macrophage phenotypes were determined using qRT‒PCR and immunohistochemical staining...
April 10, 2024: British Journal of Cancer
https://read.qxmd.com/read/38593042/cachexia-index-for-prognostication-in-surgical-patients-with-locally-advanced-oesophageal-or-gastric-cancer-multicentre-cohort-study
#15
MULTICENTER STUDY
Leo R Brown, Georgina G Thomson, Ellen Gardner, Siobhan Chien, Josh McGovern, Ross D Dolan, Stephen T McSorley, Matthew J Forshaw, Donald C McMillan, Stephen J Wigmore, Andrew B Crumley, Richard J E Skipworth
BACKGROUND: Features of cancer cachexia adversely influence patient outcomes, yet few currently inform clinical decision-making. This study assessed the value of the cachexia index (CXI), a novel prognostic marker, in patients for whom neoadjuvant chemotherapy and surgery for oesophagogastric cancer is planned. METHODS: Consecutive patients newly diagnosed with locally advanced (T3-4 or at least N1) oesophagogastric cancer between 1 January 2010 and 31 December 2015 were identified through the West of Scotland and South-East Scotland Cancer Networks...
April 3, 2024: British Journal of Surgery
https://read.qxmd.com/read/38591988/identification-of-subgroups-of-patients-with-oesophageal-cancer-based-on-exercise-intensity-during-prehabilitation
#16
JOURNAL ARTICLE
Elja A E Reijneveld, Mitchel Griekspoor, Jaap J Dronkers, Ad Kerst, Jelle P Ruurda, Cindy Veenhof
PURPOSE: To identify subgroups of patients with oesophageal cancer based on exercise intensity during prehabilitation, and to investigate whether training outcomes varied between subgroups. MATERIALS AND METHODS: Data from a multicentre cohort study were used, involving participants following prehabilitation before oesophagectomy. Hierarchical cluster analysis was performed using four cluster variables (intensity of aerobic exercise, the Borg score during resistance exercise, intensity of physical activity, and degree of fatigue)...
April 9, 2024: Disability and Rehabilitation
https://read.qxmd.com/read/38590108/review-article-contemporary-management-of-gastrointestinal-pancreatic-and-hepatic-toxicities-of-immune-checkpoint-inhibitors
#17
REVIEW
Matthew J Townsend, Isaac J Benque, Michael Li, Shilpa Grover
BACKGROUND: Immune checkpoint inhibitors (ICIs) are effective oncologic agents which frequently cause immune-related adverse events (irAEs) which can impact multiple organ systems. Onco-Gastroenterology is a novel and emerging subspecialty within gastroenterology focused on cancer treatment-related complications. Gastroenterologists must be prepared to identify and manage diverse immune-mediated toxicities including enterocolitis, hepatitis, pancreatitis and other ICI-induced toxicities...
April 8, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38572793/the-paradox-of-platypnoea-orthodeoxia-syndrome
#18
JOURNAL ARTICLE
Benjamin A Leaver, Edward R S Cliff, Michael Jefford, Samuel Fogarty, Dominica Zentner
Platypnoea-orthodeoxia is a rare clinical syndrome characterised by dyspnoea and oxygen desaturation in the upright position which improves when supine. It requires two components: a sufficiently sized anatomical vascular defect (typically intra-cardiac or intra-pulmonary) combined with a functional component that promotes positional right-to-left shunting. We describe the rare occurrence of a patient with platypnoea-orthodeoxia syndrome (POS) because of a paradoxical shunt through a patent foramen ovale caused by a large right atrial line-associated thrombus in a male with metastatic oesophageal cancer undergoing chemotherapy...
April 4, 2024: Internal Medicine Journal
https://read.qxmd.com/read/38568850/sex-related-differences-in-oncologic-outcomes-operative-complications-and-health-related-quality-of-life-after-curative-intent-oesophageal-cancer-treatment-multicentre-retrospective-analysis
#19
JOURNAL ARTICLE
Styliani Mantziari, Jessie A Elliott, Sheraz R Markar, Fredrik Klevebro, Lucas Goense, Asif Johar, Pernilla Lagergren, Giovanni Zaninotto, Richard van Hillegersberg, Mark I van Berge Henegouwen, Markus Schäfer, Magnus Nilsson, George B Hanna, John V Reynolds
BACKGROUND: Oesophageal cancer, in particular adenocarcinoma, has a strong male predominance. However, the impact of patient sex on operative and oncologic outcomes and recovery of health-related quality of life is poorly documented, and was the focus of this large multicentre cohort study. METHODS: All consecutive patients who underwent oncological oesophagectomy from 2009 to 2015 in the 20 European iNvestigation of SUrveillance after Resection for Esophageal cancer study group centres were assessed...
March 1, 2024: BJS Open
https://read.qxmd.com/read/38561688/endoscopic-diagnosis-of-gastric-and-oesophageal-cancer-in-lusaka-zambia-a-retrospective-analysis
#20
JOURNAL ARTICLE
Violet Kayamba, Malambo Mubbunu, Paul Kelly
INTRODUCTION: There are uncertainties surrounding the spectrum of upper gastrointestinal (UGI) diseases in sub-Saharan Africa. This is mainly due to the limitations of data collection and recording. We previously reported an audit of UGI endoscopic diagnoses in Zambia spanning from 1977 to 2014. We now have extended this analysis to include subsequent years, in order to provide a more comprehensive picture of how the diagnoses have evolved over 4 decades. METHODS: We combined data collected from the endoscopy unit at the University Teaching Hospital (UTH) in Lusaka during a previous review with that collected from the beginning of 2015 to the end of 2021...
April 1, 2024: BMC Gastroenterology
keyword
keyword
40066
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.